Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves denosumab in new indication

Sep. 25, 2012

Bayer submits European MAA for contraceptive patch

Sep. 21, 2012

Novel cannabinoid CB1 receptor allosteric modulators discovered at University of Aberdeen

Sep. 21, 2012

Health Canada approves Byetta added on to insulin glargine

Sep. 20, 2012

Merck & Co. patents novel dipeptidyl peptidase inhibitors

Sep. 20, 2012

Japanese researchers present novel GPR119 receptor agonists

Sep. 20, 2012

Researchers present results from taliglucerase alfa trials

Sep. 20, 2012

SBC-102 demonstrates safety and clinical activity in patients with LAL deficiency

Sep. 19, 2012

VIVUS launches once-daily Qsymia in the U.S. for weight management

Sep. 19, 2012

New ghrelin receptor antagonists disclosed by Helsinn Healthcare

Sep. 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...